Autolus Therapeutics
2.30
0.09 (4.07%)
At close: Jan 15, 2025, 12:28 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -208.38M -148.84M -142.10M -142.09M -123.85M -31.11M -19.73M -12.55M -7.46M
Depreciation & Amortization 6.57M 7.42M 8.46M 5.66M 4.61M 1.10M 1.01M 478.00K 3.64M
Stock-Based Compensation 11.20M 12.01M 9.94M 20.11M 30.21M 5.03M 3.15M 2.26M n/a
Other Working Capital 801.00K 3.95M 5.95M -29.00K -14.75M -3.23M -1.23M -1.74M n/a
Other Non-Cash Items 45.72M 13.39M 1.77M -1.50M 4.14M -1.07M 5.17M 1.20M 916.23K
Deferred Income Tax -986.00K -268.00K -72.00K -1.34M -399.00K -5.21M n/a n/a n/a
Change in Working Capital 292.00K 3.97M 4.14M 1.41M -16.20M 5.42M -795.00K -1.23M -413.95K
Operating Cash Flow -145.59M -112.31M -117.86M -117.76M -101.48M -25.85M -16.36M -9.85M -3.33M
Capital Expenditures -10.99M -10.84M -8.86M -14.68M -18.67M -8.77M -2.88M -1.85M -762.07K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a -327.00K 1.13M n/a n/a 7.92K
Investing Cash Flow -10.99M -10.84M -8.86M -14.68M -18.67M -7.65M -2.88M -1.85M -754.14K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a -3.18M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -883.00K 59.76M 38.16M -5.33M -7.06M 156.92M 127.69M 32.22M 12.23M
Financial Cash Flow -883.00K 223.61M 284.06M 74.42M 108.86M 117.49M 127.69M 32.22M 12.23M
Net Cash Flow -142.43M 72.08M 156.59M -57.34M -6.13M 86.98M 109.01M 17.86M 8.15M
Free Cash Flow -156.57M -123.15M -126.72M -132.44M -120.15M -34.62M -19.24M -11.70M -4.09M

Create Price Alert on AUTL

Your price alert will notify you when the stock price is above 2.30.

Add to Watchlist